Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...

Brain scientists have developed DeepFocus, a novel technique to reach the deep brain without invasive surgery to treat mental ...

BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...

Side effects of deep brain stimulation in people to treat Parkinson's may include impulsivity and depression. Biomedical ...

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...

In the third episode of The Deep End, Jon shares how DBS surgery went and how he and other volunteers felt in the days and weeks afterward.

Carnegie Mellon researchers developed "DeepFocus," a new method for brain stimulation that combines transnasal and transcranial electrical stimulation for minimally invasive targeting of deep brain ...

With the platform HoloSNS — created by Professor of Biomedical Engineering Cameron McIntyre and his team — physicians and ...